Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Press Releases
China Aoxing Pharmaceutical Company Reports Fiscal Year 2009 Financial Results
Halter USX China Index Up 10.59% for Third Quarter 2009
AOBO's Products Included in China's Essential Drug List
American Oriental Bioengineering's 'Jinji Capsules' and 'Boke Nasal Spray' Designated Among 'China's Top Branded Drugs of 2009'
American Oriental Bioengineering Announces Change in Independent Auditor
American Oriental Bioengineering Reports Second Quarter 2009 Financial Results
AOBO Announces New Product Launch
American Oriental Bioengineering to Report Second Quarter 2009 Financial Results on August 7, 2009
China Aoxing Pharmaceutical Company Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
American Oriental Bioengineering Honorably Elected a Top 20 Most Competitive Public Pharmaceutical Company in China
Halter USX China Index Up 40.88% for Second Quarter 2009
China Aoxing Pharmaceutical Company Announces Completion of Registration Trial of Its Leading Narcotic Drug for the Treatment of Acute Moderate to Severe Cough
China Aoxing Pharmaceutical Company Enters Agreement to Divest Non-Core Land Property
China Aoxing Pharmaceutical Company Reports Third Quarter Fiscal Year 2009 Financial Results
China Aoxing Pharmaceutical Company Acquires a Novel Menstrual Pain Drug
/C O R R E C T I O N -- American Oriental Bioengineering, Inc./
American Oriental Bioengineering Reports First Quarter 2009 Financial Results
China Aoxing Pharmaceutical Company to Present at Two Institutional Conferences in the US in May 2009
American Oriental Bioengineering Announces May 2009 Conference Participation
American Oriental Bioengineering To Report First Quarter 2009 Financial Results on May 11, 2009
China Aoxing Pharmaceutical Company Receives a New Injection Drug Approval for the Treatment of Angina
TheFortuneFinancial.Com Initializes Free Analyst Research on ZQK, AOB, MHK and VFC
American Oriental Bioengineering to Initiate a Phase One Clinical Trial in the United States of AOBO-001 Oral Capsule
American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results
American Oriental Bioengineering, Inc. to Report Fourth Quarter and Full Year 2008 Financial Results on March 9, 2009
PRC Government Grants High-Tech Status to AOBO Subsidiaries
American Oriental Bioengineering to Participate in the 2009 UBS Greater China Conference
American Oriental Bioengineering Comments on Recent Property Purchase
American Oriental Bioengineering Reports Third Quarter 2008 Financial Results
American Oriental Bioengineering Announces Participation in November Investor Conferences
American Oriental Bioengineering, Inc. to Report Third Quarter 2008 Financial Results
American Oriental Bioengineering Completes Two Acquisitions
American Oriental Bioengineering Announces Participation in September Investor Conferences
American Oriental Bioengineering Reports Second Quarter 2008 Financial Results
American Oriental Bioengineering, Inc. to Report Second Quarter 2008 Financial Results
American Oriental Bioengineering, Inc. Announces Pricing of Convertible Notes Offering
American Oriental Bioengineering Proposes Offering of $85 Million of Convertible Notes
SectorWatch.biz Issues MarketStats on Medical Products and Device Companies INCC, CMED, WX, MR and AOB - Jun 24 2008 7:01AM
SectorWatch.biz Issues MarketStats on Medical Products and Device Companies INCC, CMED, WX, MR and AOB - Jun 16 2008 6:35AM
American Oriental Bioengineering Appoints Anindya Chatterjee to Chief Strategy Officer
American Oriental Bioengineering Announces that it Withdraws Convertible Preferred Stock Offering
American Oriental Bioengineering Announces Proposed Private Offering to Raise $125 Million via Convertible Preferred Stock
American Oriental Bioengineering Announces US$75 Million Share Repurchase Program
American Oriental Bioengineering Forms Science and Technology Advisory Committee - May 27 2008 12:58AM
American Oriental Bioengineering Comments on Earthquake - May 27 2008 12:54AM
BellwetherReport.com Updated Analyst Report on SVR, AOB, PWR, and TIE - May 27 2008 1:17AM
American Oriental Bioengineering Reports First Quarter 2008 Financial Results - Jun 1 2008 7:11AM
American Oriental Bioengineering to Report First Quarter 2008 Financial Results
American Oriental Bioengineering and China Aoxing Pharmaceutical Enter Into Strategic Alliance
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia